These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 12420217)
1. The bovine papillomavirus oncoprotein E5 retains MHC class I molecules in the Golgi apparatus and prevents their transport to the cell surface. Marchetti B; Ashrafi GH; Tsirimonaki E; O'Brien PM; Campo MS Oncogene; 2002 Nov; 21(51):7808-16. PubMed ID: 12420217 [TBL] [Abstract][Full Text] [Related]
2. Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins. Ashrafi GH; Tsirimonaki E; Marchetti B; O'Brien PM; Sibbet GJ; Andrew L; Campo MS Oncogene; 2002 Jan; 21(2):248-59. PubMed ID: 11803468 [TBL] [Abstract][Full Text] [Related]
3. The E5 oncoprotein of BPV-4 does not interfere with the biosynthetic pathway of non-classical MHC class I. Araibi EH; Marchetti B; Dornan ES; Ashrafi GH; Dobromylskyj M; Ellis SA; Campo MS Virology; 2006 Sep; 353(1):174-83. PubMed ID: 16806386 [TBL] [Abstract][Full Text] [Related]
4. The E5 protein of BPV-4 interacts with the heavy chain of MHC class I and irreversibly retains the MHC complex in the Golgi apparatus. Marchetti B; Ashrafi GH; Dornan ES; Araibi EH; Ellis SA; Campo MS Oncogene; 2006 Apr; 25(15):2254-63. PubMed ID: 16288210 [TBL] [Abstract][Full Text] [Related]
5. Down-regulation of MHC class I is a property common to papillomavirus E5 proteins. Ashrafi GH; Brown DR; Fife KH; Campo MS Virus Res; 2006 Sep; 120(1-2):208-11. PubMed ID: 16780984 [TBL] [Abstract][Full Text] [Related]
6. Similarities and differences between the E5 oncoproteins of bovine papillomaviruses type 1 and type 4: cytoskeleton, motility and invasiveness in E5-transformed bovine and mouse cells. Tsirimonaki E; Ullah R; Marchetti B; Ashrafi GH; McGarry L; Ozanne B; Campo MS Virus Res; 2006 Feb; 115(2):158-68. PubMed ID: 16168512 [TBL] [Abstract][Full Text] [Related]
7. High-risk human papillomavirus E7 expression reduces cell-surface MHC class I molecules and increases susceptibility to natural killer cells. Bottley G; Watherston OG; Hiew YL; Norrild B; Cook GP; Blair GE Oncogene; 2008 Mar; 27(12):1794-9. PubMed ID: 17828295 [TBL] [Abstract][Full Text] [Related]
8. Bovine papillomavirus type 1 oncoprotein E5 inhibits equine MHC class I and interacts with equine MHC I heavy chain. Marchetti B; Gault EA; Cortese MS; Yuan Z; Ellis SA; Nasir L; Campo MS J Gen Virol; 2009 Dec; 90(Pt 12):2865-2870. PubMed ID: 19675187 [TBL] [Abstract][Full Text] [Related]
9. Immune selection in murine tumors. Ph.d thesis. Svane IM; Engel AM APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251 [TBL] [Abstract][Full Text] [Related]
10. E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I. Ashrafi GH; Haghshenas MR; Marchetti B; O'Brien PM; Campo MS Int J Cancer; 2005 Jan; 113(2):276-83. PubMed ID: 15386416 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of cell transformation by papillomavirus E5 proteins. DiMaio D; Mattoon D Oncogene; 2001 Nov; 20(54):7866-73. PubMed ID: 11753669 [TBL] [Abstract][Full Text] [Related]
12. Modulation of major histocompatibility complex (MHC) class I genes in adenovirus 12 transformed cells: interferon-gamma increases class I expression by a mechanism that circumvents E1A induced-repression and tumor necrosis factor enhances the effect of interferon-gamma. Eager KB; Pfizenmaier K; Ricciardi RP Oncogene; 1989 Jan; 4(1):39-44. PubMed ID: 2521704 [TBL] [Abstract][Full Text] [Related]
13. HPV16E7 mediates HADC chromatin repression and downregulation of MHC class I genes in HPV16 tumorigenic cells through interaction with an MHC class I promoter. Li H; Ou X; Xiong J; Wang T Biochem Biophys Res Commun; 2006 Nov; 349(4):1315-21. PubMed ID: 16979588 [TBL] [Abstract][Full Text] [Related]
14. The E5 protein of the human papillomavirus type 16 modulates composition and dynamics of membrane lipids in keratinocytes. Bravo IG; Crusius K; Alonso A Arch Virol; 2005 Feb; 150(2):231-46. PubMed ID: 15503216 [TBL] [Abstract][Full Text] [Related]
15. A recycling pathway between the endoplasmic reticulum and the Golgi apparatus for retention of unassembled MHC class I molecules. Hsu VW; Yuan LC; Nuchtern JG; Lippincott-Schwartz J; Hammerling GJ; Klausner RD Nature; 1991 Aug; 352(6334):441-4. PubMed ID: 1861723 [TBL] [Abstract][Full Text] [Related]
16. CuZn-SOD suppresses the bovine papillomavirus-induced proliferation of fibroblasts. Rausalu K; Karo-Astover L; Kilk A; Ustav M APMIS; 2007 Dec; 115(12):1415-21. PubMed ID: 18184412 [TBL] [Abstract][Full Text] [Related]
17. Immune escape phenotype of HPV16-associated tumours: MHC class I expression changes during progression and therapy. Mikysková R; Bubeník J; Vonka V; Smahel M; Indrova M; Bieblová J; Símová J; Jandlová T Int J Oncol; 2005 Feb; 26(2):521-7. PubMed ID: 15645139 [TBL] [Abstract][Full Text] [Related]
18. E5 protein of human papillomavirus 16 downregulates HLA class I and interacts with the heavy chain via its first hydrophobic domain. Ashrafi GH; Haghshenas M; Marchetti B; Campo MS Int J Cancer; 2006 Nov; 119(9):2105-12. PubMed ID: 16823848 [TBL] [Abstract][Full Text] [Related]
19. Major histocompatibility complex heavy chain accumulation in the endoplasmic reticulum of oligodendrocytes results in myelin abnormalities. Baerwald KD; Corbin JG; Popko B J Neurosci Res; 2000 Jan; 59(2):160-9. PubMed ID: 10650874 [TBL] [Abstract][Full Text] [Related]
20. The E5 protein of human papillomavirus type 16 perturbs MHC class II antigen maturation in human foreskin keratinocytes treated with interferon-gamma. Zhang B; Li P; Wang E; Brahmi Z; Dunn KW; Blum JS; Roman A Virology; 2003 May; 310(1):100-8. PubMed ID: 12788634 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]